Ciprofloxacin Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 250 mg, 500 mg, 750mg
Reference Brands: CIPROBAY (EU/UK), Cifloc (EU), Ciplox (India)
Category:
Antibiotics
Ciprofloxacin Tablet is mainly used mainly for Bacterial Infections and Healing of Bacterial Infections.
Ciprofloxacin Tablets is available in Tablets
and strengths such as 250 mg, 500 mg, 750mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ciprofloxacin Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ciprofloxacin Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ciprofloxacin Tablet is used for the treatment, control and prevention of the following diseases and symptoms: • Treatment of bacterial infections • Bacterial infections • Healing bacterial infections
Ciprofloxacin is a broad-spectrum antibiotic belonging to the fluoroquinolone class, used to treat a wide range of bacterial infections. It is FDA-approved for urinary tract infections, sexually transmitted infections such as gonorrhea and chancroid, skin and soft tissue infections, bone and joint infections, prostatitis, typhoid fever, gastrointestinal infections, lower respiratory tract infections, anthrax, plague, and salmonellosis.
Ciprofloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, essential enzymes for bacterial DNA replication and cell survival, effectively killing susceptible bacteria. Its broad coverage makes it suitable for treating mixed infections and infections in patients at risk for Gram-negative pathogens.
This antibiotic is widely used in both hospital and outpatient settings for adults and pediatric patients (where appropriate), offering effective therapy for common and complex bacterial infections. Healthcare providers must consider contraindications, drug interactions, and potential adverse effects when prescribing ciprofloxacin to ensure safe and optimal patient outcomes.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing